687
Views
74
CrossRef citations to date
0
Altmetric
Review

Diet as a Risk Factor for Cholesterol Gallstone Disease

, MD, , MD, , RD, , PhD & , MD
Pages 187-196 | Received 11 Jun 2003, Accepted 29 Oct 2003, Published online: 19 Jun 2013

REFERENCES

  • Dowling RH: Review: pathogenesis of gallstones. Alim Pharmacol Ther14 :39– 47,2000 .
  • Amigo L, Zanlungo S, Mendoza H, Miquel JF, Nervi F: Risk factors and pathogenesis of cholesterol gallstones: state of the art. Eur Rev Med Pharmacol Sci3 :241– 246,1999 .
  • Paumgartner G, Sauerbruch T: Gallstones: pathogenesis. Lancet338 :1117– 1121,1991 .
  • Miyasaka K, Takata Y, Funakoshi A: Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism. J Gastroenterol37(S14) :102– 106,2002 .
  • Nervi, F, Miquel, JF, Marshall, G: The Amerindian epidemics of cholesterol gallstones: The North and South connection. Hepatology37 :947– 948,2003 .
  • Carey MC, and Paigen B: Epidemiology of the American Indians’ burden and its likely genetic origins. Hepatology36 :781– 791,2002 .
  • Bennion LJ, Grundy SM: Risk factors for the development of cholelithiasis in man (first of two parts). N Engl J Med299 :1161– 1167,1978 .
  • Bennion LJ, Grundy SM: Risk factors for the development of cholelithiasis in man (second of two parts). N Engl J Med299 :1221– 1227,1978 .
  • Folson AR: Insulin resistance and cardiovascular disease. In Reaven GM, Laws A (eds): “Insulin Resistance: The Metabolic Syndrome X.” Totowa, NJ: Humana Press, pp333– 346,1999 .
  • Stern MP, Mitchell BD: Genetics of insulin resistance. In Reaven GM, Laws A (eds): “Insulin Resistance: The Metabolic Syndrome X.” Totowa, NJ: Humana Press, pp3– 18,1999 .
  • Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P, Rizzetto M: Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association. Hepatology35 :367– 372,2002 .
  • Marchesini G, Forlani G: NASH: from liver diseases to metabolic disorders and back to clinical hepatology Hepatology35 :497– 499,2002 .
  • Ruhl C, Everhart J: Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology31 :299– 303,2000 .
  • Diehl AK: Cholelithiasis and the insulin resistance syndrome. Hepatology31 :528– 529,2000 .
  • Hayes KC, Livingston A, Trautwein EA: Dietary impact on biliary lipids and gallstones. Annu Rev Nutr12 :299– 326,1992 .
  • Caroli-Bose FX, Deveau C, Peten EP, Delabre P, Zanaldi H, Hebuterne X, Hastier P, Viudes F, Belanger F, Caroli-Bosc C, Harris A, Hardion M, Rampal P, Delmont J-P: Cholelithiasis and dietary risk factors. An epidemiological investigation in Vidauban, Southeast France. Dig Dis Sci43 :2131– 2137,1998 .
  • Ortega RM, Fernández-Azuela M, Encinas-Sotillo A, Andres P, Lopez-Sobaler AM: Differences in diet and food habits between patients with gallstones and controls. J Am Coll Nutr16 :88– 95,1997 .
  • Attili AF, Scafato E, Marchioli R, Marfisi RM, Festi D: Diet and gallstones in Italy: the cross-sectional MICOL results. Hepatology27 :1492– 1498,1998 .
  • Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willet WC: Weight, diet and the risk of symptomatic gallstones in middle-aged women. N Engl J Med321 :563– 569,1989 .
  • Sichieri R, Everhart JE, Roth H: A prospective study of hospitalization with gallstone disease among women. Role of dietary factors, fasting period and dieting. Am J Public Health8 :880– 884,1991 .
  • Moerman CJ, Smeets FW, Kromhout D: Dietary risk factors for clinically diagnosed gallstones in middle-aged men. A 25-year follow-up study (the Zutphen Study). Ann Epidemiol4 :248– 254,1994 .
  • Jorgensen T, Jorgensen LM: Gallstones and diet in a Danish population. Scand J Gastroenterol24 :821– 826,1989 .
  • Jonnalagadda SS, Trautwein EA, Hayes KC: Dietary fats rich in saturated fatty acids (12:0, 14:0, and 16:0) enhance gallstone formation to monounsaturated fat (18:1) in cholesterol - fed hamsters. Lipids30 :415– 424,1995 .
  • Misciaga G, Centonze S, Leoci C, Guerra V, Cisternino AM, Ceo R, Trevisan M: Diet, physical activity, and gallstones - a population-based, case-control study in southern Italy. Am J Clin Nutr69 :120– 126,1999 .
  • Ohshima A, Cohen BI, Ayyad N, Mosbach EH: Dietary Fat Alters Biliary Lipid Secretion in the Hamster. Lipids31 :948– 954,1996 .
  • Mizuguchi K, Yano T, Kawano H, Abei M, Tanaka N: Preventive effects of eicosapentanoic acid (EPA) on cholesterol gallstone formation in hamsters. Nippon Yakurigaku Zasshi110(S1) :50– 55,1997 .
  • Schaefer O: When the Eskimo come to town. Nutr Today8 :16 ,1971 .
  • Scobey MW, Johnson FL, Parks JS, Rudell LL: Dietary fish oil effects on biliary lipid secretion and cholesterol gallstone formation in the African Ghreen monkey. Hepatology14 :679– 684,1991 .
  • Magnuson TH, Lillemoe KD, High RC, Pitt HA: Dietary fish oil inhibits cholesterol crystal nucleation and gallstone formation in the prairie dog. Surgery118 :517– 523,1995 .
  • Booker ML, Scott TE, LaMorte WW: Effects of dietary fish oil on biliary phospholipids and prostaglandin synthesis in the cholesterol-fed prairie dog. Lipids25 :27– 31,1990 .
  • Berr F, Holl J, Jungst D, Fischer S, Richter WO, Seifferth B, Paumgartner G: Dietary n-3 polyunsaturated fatty acids decrease biliary cholesterol saturation in gallstone disease. Hepatology16 :960– 967,1992 .
  • Tierney S, Ahrendt SA, Talbot KF: Fish oil reduces biliary cholesterol and prolongs nucleation of human gallbladder bile. Gastroenterology104 :380A ,1993 .
  • Méndez-Sánchez N, González V, Aguayo P, Sánchez JM, Tanimoto MA, Elizondo J, Uribe M: Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight. J Nutr131 :2300– 2303,2001 .
  • Berenson MM, Cardinal JR: Calcium accelerates cholesterol phase transitions in analog bile. Experientia41 :1328– 1330,1985 .
  • DenBesten L, Safaie-Shirazi S, Connor WE, Bell S: Early changes in bile composition and gallstone formation induced by a high cholesterol diet in praire dogs. Gastroenterology66 :1036– 1045,1974 .
  • Osuga T, Portman DW: Experimental formation of gallstones in the squirrel monkey. Proc Soc Exp Biol Med136 :722– 726,1971 .
  • Pearlman BH, Bonorris GG, Phillips MJ: Cholesterol gallstone formation and prevention by chenodeoxycholic and ursodeoxycholic acids. A new hamster model. Gastroenterology77 :634– 641,1979 .
  • Tepperman J, Caldwell FT, Tepperman HM: Induction of gallstones in mice by feeding a cholesterolcholic acid containing diet. Am J Physiol206 :628– 634,1964 .
  • Bergman F, van der Linden W: Reaction of the mongolian gerbil to a colesterol-cholic acid-containing gallstone inducing diet. Acta Path Microbiol Scan79A :476– 486,1971 .
  • Ho KJ: Comparative studies on the effect of cholesterol feeding on biliary composition. Am J Clin Nutr29 :698– 704,1976 .
  • DenBesten L, Connor WE, Bell S: The effect of dietary cholesterol on the composition of human bile. Surgery73 :266– 73,1973 .
  • Grundy SM, Mok HYI: Effect of diets and drugs on biliary cholesterol secretion in man. In Fisher MM, Goresky CA, Shaffer EA, Strasbert FM (eds): “Gallstones.” New York, NY: Plenum, pp238– 298,1979 .
  • Lee DWT, Gilmore CJ, Bonorris G, Cohen H, Marks JW, Cho-Sue M, Meiselman MS, Schoenfield LJ: Effect of dietary cholesterol on biliary lipids in patients with gallstones and normal subjects. Am J Clin Nutr42 :414– 420,1985 .
  • Dam H, Prange I, Jensen MK, Kallehauge HE, Fenger HJ: Studies on human bile IV. Influence of cholesterol in the form of eggs on the composition of bile in health subjects. Z Ernaehrungswiss10 :178– 187,1971 .
  • Andersen E, Hellstrom K: The effect of cholesterol feeding on bile acid kinetics and biliary lipids in normolipidemic and hypertriglyceridemic subjects. J Lipid Res20 :1020– 1027,1979 .
  • Tandon RK, Saraya A, Paul S, Kapur BM: Dietary habits of gallstone patients in Northern India. J Clin Gastroenterol22 :23– 27,1996 .
  • Diehl AK, Haffner SM, Knapp JA, Hazuda HP, Stern MO: Dietary intake and the prevalence of gallbladder disease in Mexican Americans. Gastroenterology97 :1527– 1533,1989 .
  • Goswami SK, Frey CF: Effect of Beta-sitosterol on cholesterol-cholic acid-induced gallstone formation in mice. Am J Gastroenterol65 :305– 310,1976 .
  • Volger OL, van der Boom H, de Wit EC, van Duyvenvoorde W, Hornstra G, Plat J, Havekes LM, Mensink RP, Princen HM: Dietary plant stanol esters reduce VLDL cholesterol secretion and bile saturation in apolipoprotein E*3-LEiden transgenic mice. Arterioscler Thromb Vasc Biol21 :1046– 1052,2001 .
  • Ulloa N, Nervi F: Mechanism and kinetic characteristics of the uncoupling by plant steroids of biliary cholesterol from bile salt output. Biochim Biophys Acta837 :181– 189,1985 .
  • Oakenfull D: Saponins in food. A review. Food Chem6 :19– 40,1981 .
  • Nervi F, Covarrubias C, Bravo P, Velasco N, Ulloa N, Cruz F, Fava M, Severin C, Del Pozo R, Antezana C: Influence of legume intake on biliary lipids and cholesterol saturation in young Chilean men. Gastroenterology96 :825– 830,1989 .
  • Duane WC: Effects of legume consumption on serum cholesterol, biliary lipids, and sterol metabolism in humans. J Lipid Res38 :1120– 1128,1997 .
  • Rigotti A, Marzolo MP, Ulloa N, González O, Nervi F: Effect of bean intake on biliary lipid secretion and on hepatic cholesterol metabolism in rat. J Lipid Res30 :1041– 1048,1989 .
  • Amigo L, Marzolo MP, Aguilera JM, Hohlberg A, Cortés M, Nervi F: Influence of different dietary constituents of beans (phaseolus vulgaris) on serum and biliary lipids in the rat. J Nutr Biochem3 :486– 490,1992 .
  • Scragg RK, McMichael AJ, Baghurst PA: Diet, alcohol, and relative weight in gallstone disease: a case-control study. Br Med J288 :1113– 1119,1984 .
  • Thornton JR, Emmet P, Heaton KW: Diet and gallstones: Effect of refined and unrefined carbohydrate diets on bile cholesterol saturation and bile acid metabolism. Gut24 :2– 6,1983 .
  • Moran S, Uribe M, Prado ME, de la Mora G, Muñoz RM, Perez MF, Milke P, Blancas JM, Dehesa M: Effects of fiber administration in the prevention of gallstones in obese patients on a reducing diet. A clinical trial. Rev Gastroenterol Mex62 :266– 272,1997 .
  • Marcus SN, Wheaton KW: Intestinal transit rate, deoxycholic acid and the cholesterol saturation of bile-three interrelated factors. Gut27 :550– 558,1986 .
  • Marcus SN, Wheaton KW: Effects of a new, concentrated wheat fiber preparation on intestinal transit, deoxycholic acid metabolism and the composition of bile. Gut27 :893– 900,1986 .
  • Low-Beer TS: Nutrition and cholesterol gallstones. Proc Nutr Soc44 :127– 134,1985 .
  • Schwesinger WH, Kurtin WE, Page CP, Stewart RM, Johnson R: Soluble dietary fiber protects against cholesterol gallstone formation. Am J Surg177 :307– 310,1999 .
  • Simon JA: Ascorbic acid and cholesterol gallstones. Med Hypotheses40 :81– 84,1993 .
  • Gustafsson U, Wang FH, Axelson M, Kallner A, Sahlin S, Einarsson K: The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time. Eur J Clin Invest27 :387– 391,1997 .
  • Simon JA, Hudes ES: Serum ascorbic acid and gallbladder disease. Prevalence among US adults. The Third National Health and Nutrition Examination Survey. Arch Intern Med160 :931– 936,2000 .
  • Simon JA, Grady D, Snabes MC, Fong J, Hunninghake DB: Ascorbic acid supplements use and the prevalence of gallbladder disease. J Clin Epidemiol51 :257– 265,1998 .
  • Simon JA, Hudes ES: Serum ascorbic acid and other correlates of gallbladder disease among US adults. Am J Public Health88 :1208– 1212,1998 .
  • Williams CN, Johnston JL: Prevalence of gallstones and risk factors in Caucasian women in a rural Canadian community. Can Med Assoc J122 :664– 668,1980 .
  • Sarles H, Chabert C, Pommeau Y, Save E, Mouret H, Gerolami A: Diet and cholesterol gallstones: a study of 101 patients with cholelithiasis compared to 101 matchet controls. Am J Dig14 :531– 537,1969 .
  • Worthington HV, Hunt LP, McCloy RF, Maclennan I, Braganza JM: A pilot study of antioxidant intake in patients with cholesterol gallstones. Nutrition13 :118– 127,1997 .
  • Reid SM, Fullmer SD, Pettigrew KD, Burch TA, Bennett PH, Miller M, Whedon GD: Nutrient intake of Pima Indian women: relationships to diabetes mellitus and gallbladder disease. Am J Clin Nutr24 :1281– 1289,1971 .
  • Pastides H, Tzonou A, Trichopoulos D, Katsouyanni K, Trichopoulou A, Kefalogiannis N, Manousos O: A case-control study of the relationship between smoking, diet, and gallbladder disease. Arch Intern Med150 :1409– 1412,1990 .
  • Attili AF: Dietary habits and cholelithiasis. In Capocaccia I, Ricci G, Agelico F, Attili AF (eds): “Epidemiology and Prevention of Gallstone Disease.” Lancaster, England: MTP Press, pp175– 181,1984 .
  • Fornari F, Imbberti D, Squillante MM, Squassante L, Civardi G, Buscarini E, Cabaña L, Caturelli E, Buscarini L: Incidence of gallstones in a population of patients with cirrhosis. J Hepatol20 :797– 801,1994 .
  • Diehl AK, Haffner SM, Hazuda HP, Stern MP: Coronary risk factors and clinical gallbladder disease: An approach to the prevention of gallstones? Am J Public Health77 :841– 845,1987 .
  • Nestel PJ, Simons LA, Homma Y: Effects of ethanol on bile acid and cholesterol metabolism. Am J Clin Nutr29 :1007– 1015,1976 .
  • Topping DL, Weller RA, Nader CJ, Calvert GD, Illman RJ: Adaptative effects of dietary ethanol in the pig: Changes in plasma high-density lipoproteins and fecal steroid excretion and mutagenecity. Am J Clin Nutr36 :245– 250,1982 .
  • Yoshida T, McCormick WC, Swell L, Vlahcevic ZR: Bile acid metabolism in cirrhosis IV. Characterization of the abnormality in deoxycholic acid metabolism. Gastroenterology68 :335– 341,1975 .
  • Thijs C, Knipschild P, Brombacher P: Serum lipids and gallstones: A case-control study. Gastroenterology99 :843– 849,1990 .
  • Rakic V: A controlled trial of the effects of pattern of alcohol intake on serum lipid level in regular drinkers. Atherosclerosis137 :243– 252,1998 .
  • Gaziano JM, Buring IE, Breslow JL, Goldhaber SZ, Rosner B, VanDerburgh M, Willett W, Hennekens CH: Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med329 :1829– 1834,1993 .
  • Douglas BR, Jansen JB, Tham RT, Lamers CB: Coffee stimulation of cholecystokinin release and gallbladder contraction in human. Am J Clin Nutr52 :553– 556,1990 .
  • Keiner F: The effect of coffee on gallbladder contraction. Medizinische Welt34 :1907– 1912,1965 .
  • Mangunson TH, Zarkin BA, Lillemoe KD, May CA, Bastidas JA, Pitt HA: Caffeine inhibits gallbladder absorption. Curr Surg46 :477– 479,1989 .
  • Lillemoe KD, Magnuson TH, High RC, Peoples GE, Pitt HA: Caffeine prevents cholesterol gallstone formation. Surgery106 :400– 406,1989 .
  • Brown SR, Cann PA, Read NW: Effect of coffee on distal colon function. Gut31 :450– 453,1990 .
  • Rustan AC, Halvorsen B, Huggett AC, Ranheim T, Drevon CA: Effect of coffee lipids (cafestol and kahweol) on regulation of cholesterol metabolism in HepG2 cells. Arterioscler Thromb Vasc Biol17 :2140– 2149,1997 .
  • Halvorsen B, Ranheim T, Nenseter MS, Huggets AC, Drevon CA: Effect of a coffee lipid (cafestol) on cholesterol metabolism in human skin fibroblasts. J Lip Res39 :901– 912,1998 .
  • Misciagna G, Leoci C, Guerra V, Chiloiro M, Elba S, Petruzzi J, Mossa A, Noviello MR, Coviello A, Minutolo MC, Mangini V, Messa C, Cavallini A, De Michele G, Giorgio I: Epidemiology of cholethiasis in southerm Italy. Part II: Risk factors. Eur J Gastroenterol Hepatol8 :585– 593,1996 .
  • Leitzmann MF, Willett WC, Rimm EB, Stampfer MJ, Spiegelman D, Colditz GA, Giovannucci EL: A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA281 :2106– 2112,1999 .
  • Ruhl CE, Everhart JE: Association of coffee consumption with gallbladder disease. Am J Epidemiol152 :1034– 1038,2000 .
  • Sahi T, Pafferbarger RS, Hsieh CC, Lee IM: Body mass index, cigarette smoking, and other characteristics as predictors of self-reported, physician-diagnosed gallbladder disease in male college alumni. Am J Epidemiol147 :644– 651,1998 .
  • La Vecchia C, Negri E, D’Avanzo B, Franceschi S, Boyle P: Risk factors for gallstone disease requiring surgery. Int J Epidemiol20 :209– 215,1991 .
  • Jorgensen T: Gallstones in a Danish population: relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus. Gut30 :528– 534,1989 .
  • Basso L, McCollum PT, Darling MR, Tocchi A, Tanner WA: A descriptive study of pregnant women with gallstones: relation to dietary and social habits, education, physical activity, height, and weight. Eur J Epidemiol8 :629– 633,1992 .
  • Leitzmann MF, Stampfer MJ, Willett WC, Spiegelman D, Colditz GA, Giobannucci EL: Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology123 :1823– 1830,2002 .
  • Kratzer W, Kachele V, Mason RA, Muche R, Hay B, Wiesneth M, Hill V, Beckh K, Adler G: Gallstone prevalence in relation to smoking, alcohol, coffee consumption, and nutrition: the Ulm gallstone study. Scand J Gastroenterol32 :953– 958,1992 .
  • Kono S, Ikeda N, Yanai F, Yamamoto M, Shinchi K, Imanishi K: Dietary habits and gallstones: a study of male self-defense officials in Japan. In Capocaccia L (ed): “Recent Advances in the Epidemiology and Prevention of Gallstone Disease.” Dordrecht, Netherlands: Kluwer Academic Press, pp129– 137,1991 .
  • Horton JD, Goldstein JL, Brown MS: SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest109 :1125– 1131,2002 .
  • Xu J, Teran-Garcia M, Park JHY, Nakamura MT, Clarke SD, Shimomura I, Bashmakov Y, Horton JD: Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem274 :30028– 30032,1999 .
  • Foretz M, Guichard C, Ferre P, Foufelle F: Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA96 :12737– 12742,1999 .
  • Xu J, Nakamura MT, Cho HP, Clarke SD: Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. J Biol Chem274 :23577– 23583,1999 .
  • Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ: Nuclear receptors and lipid physiology: opening the x-files. Science294 :1866– 1870,2001 .
  • Edwards PA, Kast HR, Anisfeld AM: BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res43 :2– 12,2002
  • Ou J, Tu H, Shan B, Luk A, DeBose-Boyd RA, Bashmakov Y, Goldstein JL, Brown MS: Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci USA98 :6027– 6032,2001 .
  • Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ: Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell102 :731– 744,2000 .
  • Kok T, Walters H, Blocks WW, Havinga R, Jansen PLM, Stales B, Knipers F: Induction of hepatic ABC transport is part of the PPARα-mediated fasting response in the mouse. Gastroenterology124 :160– 171,2003 .
  • Stahlberg D, Reihner E, Rudling M, Berglund L, Einarsson K, Angelin B: Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol alpha-hydroxylase. Hepatology21 :1025– 1030,1995 .
  • Miquel JF, Covarrubias C, Villarroel L, Mingrone G, Greco AV, Carvallo P, Marshall G, Del Pino G, Nervi F: Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics and Maoris. Gastroenterology115 :937– 946,1998 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.